Table I Index
Table of Contents
Table I - 33 Henry Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
Number | Rate | Number | Rate | Number | Rate | |
All sites | 230 | 343.2 | 126 | 434.3 | 104 | 282.0 |
Oral cavity and pharynx | * | # | * | # | * | # |
Lip | * | # | * | # | * | # |
Tongue | * | # | * | # | * | # |
Major salivary glands | * | # | * | # | * | # |
Floor of mouth | * | # | * | # | * | # |
Gum and other mouth | * | # | * | # | * | # |
Nasopharynx | * | # | * | # | * | # |
Tonsil | * | # | * | # | * | # |
Oropharynx | * | # | * | # | * | # |
Hypopharynx | * | # | * | # | * | # |
Pharynx and other oral cavity | * | # | * | # | * | # |
Digestive system | 45 | 61.9 | 30 | 99.3 | 15 | 38.0** |
Esophagus | * | # | * | # | * | # |
Stomach | * | # | * | # | * | # |
Small intestine | * | # | * | # | * | # |
Colon excluding rectum | 24 | 32.8 | 15 | 48.7** | 9 | 24.2** |
Rectum and rectosigmoid | 6 | 8.3** | * | # | * | # |
Anus, anal canal, and anorectum | * | # | * | # | * | # |
Liver and intrahepatic bile duct | * | # | * | # | * | # |
Gallbladder | 5 | 6.2** | * | # | * | # |
Other biliary | * | # | * | # | * | # |
Pancreas | * | # | * | # | * | # |
Retroperitoneum | * | # | * | # | * | # |
Peritoneum | * | # | * | # | * | # |
Other digestive organs | * | # | * | # | * | # |
Respiratory system | 46 | 72.1 | 32 | 114.8 | 14 | 36.4** |
Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
Larynx | * | # | * | # | * | # |
Lung and bronchus | 42 | 65.4 | 29 | 103.9 | 13 | 34.0** |
Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
Bones and joints | * | # | * | # | * | # |
Soft tissue (including heart) | * | # | * | # | * | # |
Skin (excluding basal and squamous) | * | # | * | # | * | # |
Melanoma of the skin | * | # | * | # | * | # |
Other non-epithelial skin cancers | * | # | * | # | * | # |
Breast | 29 | 47.0 | * | # | 29 | 86.0 |
Female genital system | 17 | 25.5** | -- | -- | 17 | 47.8** |
Cervix uteri | * | # | -- | -- | * | # |
Corpus uteri | 7 | 10.5** | -- | -- | 7 | 19.8** |
Uterus, NOS | * | # | -- | -- | * | # |
Ovary | 6 | 9.6** | -- | -- | 6 | 18.3** |
Vagina | * | # | -- | -- | * | # |
Vulva | * | # | -- | -- | * | # |
Other female genital organs | * | # | -- | -- | * | # |
Male genital system | 32 | 49.3 | 32 | 112.5 | -- | -- |
Prostate gland | 31 | 46.3 | 31 | 106.6 | -- | -- |
Testis | * | # | * | # | -- | -- |
Penis | * | # | * | # | -- | -- |
Other male genital organs | * | # | * | # | -- | -- |
Urinary system | 20 | 25.1 | 11 | 36.2** | 9 | 19.4** |
Urinary bladder | 16 | 19.8** | 10 | 32.2** | 6 | 14.0** |
Kidney and renal pelvis | * | # | * | # | * | # |
Ureter | * | # | * | # | * | # |
Other urinary organs | * | # | * | # | * | # |
Eye and orbit | * | # | * | # | * | # |
Brain and other nervous system | * | # | * | # | * | # |
Brain | * | # | * | # | * | # |
Other nervous system | * | # | * | # | * | # |
Endocrine system | 5 | 7.7** | * | # | * | # |
Thyroid gland | 5 | 7.7** | * | # | * | # |
Other endocrine (including thymus) | * | # | * | # | * | # |
Lymphoma | 5 | 7.2** | * | # | * | # |
Hodgkin’s disease | * | # | * | # | * | # |
Non-Hodgkin’s lymphoma | * | # | * | # | * | # |
Multiple myeloma | 5 | 7.7** | * | # | * | # |
Leukemia | 6 | 9.0** | * | # | * | # |
Acute lymphocytic | * | # | * | # | * | # |
Chronic lymphocytic | * | # | * | # | * | # |
Acute myeloid | * | # | * | # | * | # |
Chronic myeloid | * | # | * | # | * | # |
Other leukemias | * | # | * | # | * | # |
Other, ill-defined and unknown sites | 7 | 10.0** | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |